Modern Chi Med Reports Stable Share Capital and Sufficient Public Float in August 2026 Monthly Return

Bulletin Express09-03

Modern Chinese Medicine Group Co., Ltd. (Modern Chi Med) disclosed its Monthly Return for Equity Issuer for the period ended 31 August 2026, confirming unchanged capital structure and compliance with Hong Kong Exchange public-float requirements.

Authorised Share Capital • Authorised shares remained at 10.00 billion ordinary shares with a par value of HKD 0.01, representing total authorised capital of HKD 100.00 million. No increase or decrease was recorded during the month.

Issued Shares • Issued ordinary shares were steady at 720.00 million, with no treasury shares held. • Consequently, total issued share capital stood unchanged at 720.00 million shares.

Public Float Compliance • The company affirmed that it met the Main Board’s minimum public-float threshold of 25 % of issued shares as at 31 August 2026.

Capital Instruments • The return shows no outstanding share options, warrants, convertibles or other equity-linked agreements.

Corporate Authorisation • The filing was signed by Executive Director Zhang Hongli and submitted on 03 September 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment